Campbell & Co Investment Adviser’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,947
Closed -$2.24M 1126
2025
Q4
$2.24M Buy
+53,947
New +$2.19M 0.11% 296
2025
Q2
Sell
-8,926
Closed -$497K 1177
2025
Q1
$497K Sell
8,926
-13,229
-60% -$633K 0.04% 679
2024
Q4
$959K Buy
22,155
+8,086
+57% +$360K 0.07% 409
2024
Q3
$721K Sell
14,069
-1,576
-10% -$106K 0.05% 567
2024
Q2
$990K Buy
15,645
+8,637
+123% +$518K 0.08% 369
2024
Q1
$464K Sell
7,008
-1,004
-13% -$81.5K 0.04% 733
2023
Q4
$787K Sell
8,012
-4,605
-36% -$401K 0.07% 496
2023
Q3
$1.01M Buy
12,617
+8,897
+239% +$698K 0.12% 262
2023
Q2
$300K Buy
+3,720
New +$348K 0.05% 665

Other funds holding CNXC

Campbell & Co Investment Adviser's CNXC Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 53,947 shares — an estimated $2.24M sold.

Campbell & Co Investment Adviser first reported a position in CNXC in Q2 2023 and held it in 9 quarters. The position peaked at $2.24M in Q4 2025. 302 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Campbell & Co Investment Adviser reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 53,947 Concentrix shares in Q1 2026, an estimated $2.24M.
  • Campbell & Co Investment Adviser first reported a position in Concentrix in Q2 2023 and held it in 9 quarters.
  • Campbell & Co Investment Adviser's Concentrix position peaked at $2.24M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.